A randomized trial of remimazolam or inhalant on postoperative quality of recovery after general anesthesia

The effect of total intravenous anesthesia with remimazolam or balanced anesthesia on postoperative quality of recovery: A randomized controlled trial.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0006288

Enrollment

168

Registered

2021-06-23

Start date

2021-07-05

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : Balanced anesthesia is conducted in the control group. Desflurane is maintaing agent and remifentanil is infused for intraopeartive analgesia. Total intravenous anesthesia is conducted in the

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Patients undergoing laparoscopic cholecystectomy or gynecological robotic surgery - between 19 years old and 65 years old - American Society of Anesthesiologist physical status classification (ASA PS classification) = III - estimated duration of anesthesia : 2 hours or less

Exclusion criteria

Exclusion criteria: - Ambulatory cases - cases where a transfer is predicted to intensive care unit - cases where intensive care is applied - Body mass index 30 or higher - Pregnant or breast-feeding - Child-Turcotte-Pugh class C - Acute narrow-angle glaumcoma - incommunicable - cognitive impairment - not comprehensive to the informed consent

Design outcomes

Primary

Measure	Time frame
QoR-40	—

Secondary

Measure	Time frame
hypotensive event;time to extubation;time to discharge to the PACU;postoperative pain in the PACU;recovery duration;administration of rescue anti-emetics	—

Countries

Korea, Republic of

Contacts

Public ContactSeung Woo Song

Yonsei University Wonju College of Medicine

yonfong@yonsei.ac.kr+82-33-741-1536

Outcome results